Tom Van Der Hulle

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Journal: Thrombosis research

Published: June 02, 2026

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Journal: Clinical pharmacokinetics

Published: May 19, 2026

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

Journal: European urology

Published: May 07, 2026

Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 10, 2026

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Journal: Clinical pharmacokinetics

Published: March 12, 2026

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

Journal: Neuro-oncology practice

Published: December 03, 2025

Digital solutions, real-world challenges: lessons from mHealth trials in oncology.

Digital solutions, real-world challenges: lessons from mHealth trials in oncology.

Journal: Frontiers in digital health

Published: October 09, 2025

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Journal: Clinical pharmacokinetics

Published: October 01, 2025

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Journal: Clinical pharmacokinetics

Published: October 01, 2025

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 25, 2025

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1).

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1).

Journal: Clinical pharmacokinetics

Published: August 20, 2025

Outcomes of anticoagulation treatment for renal cell carcinoma tumor thrombi: a systematic review.

Outcomes of anticoagulation treatment for renal cell carcinoma tumor thrombi: a systematic review.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 19, 2025

Showing 1-12 of 96

Last Updated: 09/26/2026